Hepatic fatty acid profile of rats with AIN-93 dietinduced steatosis attenuated by the partial substitution of soybean oil by diheptanoin and triheptanoin;Perfil em ácidos graxos hepáticos de ratos com esteatose induzida pela dieta AIN-93 atenuada pela substituição parcial do óleo de soja por dieptanoína e trieptanoína

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 54, Issue 6, 2010, Pages 584-587

  Bueno, Nassib Bezerra ^a   da Silva, Maria Adriana Firmino ^a   de Melo, Ingrid Sofia Vieira ^a   da Ataíde, Terezinha da Rocha ^a   de Oliveira, Suzana Lima ^a   Ana, Antönio Euzébio Goulart Sant ^a  

^a FEDERAL UNIVERSITY OF ALAGOAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957741677     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302010000600014     Document Type: Article

References (13)

1. Silva MAF, Ataide TR, Oliveira SL, Sant'Ana AEG, Cabral Jr CR, Balwani MC, et al. Efeito hepatoprotetor do consumo crônico de dieptanoína e trieptanoína contra a esteatose em ratos. Arq Bras Endocrinol Metab. 2008;52:1145-1155.
2. Ataíde TR, Oliveira SL, Silva FM, Vitorino-Filha LG, Tavares MC, Sant'Ana AEG. Toxicological analysis of the chronic consumption of diheptanoin and triheptanoin in rats. Int J Food Sci and Technol. 2009;44:484-492.
3. Hulbert AJ, Turner N, Storlien LH, Else PL. Dietary fats and membrane function: implications for metabolism and disease. Biol Rev. 2005;80:155-169.
4. Pan DA, Storlien LH. Dietary lipid profile is a determinant of tissue phospholipid fatty acid composition and rate of weight gain in rats. J Nutr. 1993;123(3):512-519.
5. Reeves PG. Components of the AIN-93 diets as improvements in the AIN-76 a diet. J Nutr. 1997;127:838-841.
6. Gilani GS, Ratnayake WM, Brooks SP, Botting HG, Plouffe LJ, Lampi BJ. Effects of dietary protein and fat on cholesterol and fat metabolism in rats. Nutr Res. 2002;22:297-311.
7. Lucena ALM, Oliveira SL, Ataíde TR, Silva AX, Cabral Jr. CR, Oliveira MAR, et al. High-fat diet based on trienantin has no adverse metabolic effects in rats. Eur J Lipid Sci Technol. 2010;112(2):166-172.
8. Oliveira CPMS, Coelho AMM, Barbeiro HV, Lima VMR, Soriano F, Ribeiro C, et al. Liver mitochondrial dysfunction and oxidative stress in the pathogenesis of experimental nonalcoholic fatty liver disease. Braz J Med Biol Res. 2006;39(2):189-194.
9. Begriche K, Igoudjil A, Pessayre D, Fromenty B. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion. 2006;6:1-28.
10. Li Z, Berk M, McIntyre TM, Gores GJ, Feldstein AE. The lysosomalmitochondrial axis in free fatty acid-induced hepatic lipotoxicity. Hepatology. 2008;47(5)1495-1503.
11. Gentile CL, Pagliassotti MJ. The role of fatty acids in the development and progression of nonalcoholic fatty liver disease. J Nutr Biochem. 2008;19:567-576.
12. Wieckowska A, Zein NN, Yerian LM, Lopez AR, McCullough AJ, Feldstein AE. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology. 2006;44:27-33.
13. Clarke SD, Thuillier P, Baillie RA, Sha X. Peroxisome proliferatoractivated receptors: family lipid-activated transcription factors. Am J Clin Nutr. 1999;70:566-571.